Treatment of Pericardial Effusion in Cancer Patients
Pericardial effusion is the most common cardiac complication in cancer patients. Lung and breast cancers are the most common solid tumors associated with pericardial effusion. Multimodal tumor therapy improves the overall survival rate and reduces tumor complications. However, these patients need individualized treatment. This paper describes the treatment experience of pericardial effusion, from its pathophysiology, the correct classification of pericardial effusion related to malignant tumor, malignant pericardial effusion or pericardial cancer, to the methods of diagnosis and treatment. The incidence of pericardial effusion in our hospital was 12%. In 11 years of pericardial fenestration, pericardiectomy and subcutaneous catheter (tunneling) installation of pericardium or temporary pleurisy, the postoperative mortality was 1.2%, while the recurrence rate of pericardial effusion was 2.1%, and the recurrence rate of pericardial effusion was 33%. Malignant pericardial effusion is an oncologic emergency. It requires cost-effective management without increasing the incidence of patients who have deteriorated. Thoracoscopic pericardial fenestration (vats) and anterolateral small incision are ideal surgical approaches for malignant pericardial effusion.
Klatt EC, Heitz DR, 1990, Cardiac Metastases. Cancer, 65:1456–9.
Pohjola-Sintonen S, Tötterman KJ, Salmo M, et al., 1987, Late Cardiac Effects of Mediastinal Radiotherapy in Patients with Hodgkin’s Disease. Cancer, 60:31–7.
Cullinane CA, Paz IB, Smith D, et al., 2004, Prognostic Factors in the Surgical Management of Pericardial Effusion in the Patient with Concurrent Malignancy. Chest, 125:1328–34.
Gornik H, Gerhard-Herman M, Beckman JA, 2005, Abnormal Cytology Predicts Poor Prognosis in Cancer Patients with Pericardial Effusion. J Clin Oncol, 23:5211–6.
Tsang TS, Seward JB, Barnes ME, et al., 2000, Outcomes of Primary and Secondary Treatment of Pericardial Effusion in Patients with Malignancy. Mayo Clin Proc, 75:248–53.
Ferlay J, Soerjomataram I, Dikshit R, et al., 2014, Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. Int J Cancer, 136:E359–86.
Abraham KP, Reddy V, Gattuso P, 1990, Neoplasms Metastatic to the Heart: Review of 3314 Consecutive Autopsies. Am J Cardiovasc Pathol, 3:195–8.
McDonald JM, Meyers BF, Guthrie TJ, et al., 2003, Comparison of Open Subxyphoid Pericardial Drainage with Percutaneous Catheter Drainage for Symptomatic Pericardial Effusion. Ann Thorac Surg, 76:811–5.
Kim SH, Kwak MH, Park S, et al., 2010, Clinical Characteristics of Malignant Pericardial Effusion Associated with Recurrence and Survival. Cancer Res Treat, 42:210–6.
Akhter SA, 2011, The Heart and Pericardium. Thorac Surg Clin, 21:205–17.
Kaiser L, Kron IL, Spray TL, 2013, Mastery Cardiothoracic Surgery (3rd edn.). Philadelphia: Wolters Kluwer, pp.289–95.
Echeverri D, Matta L, 2014, Pericarditis Tuberculosa. Biomédica, 34:528–34.
Gottdiener JS, Appelbaum FR, Ferrans VJ, et al., 1981, Cardiotoxicity Associated with High-Dosecyclophosphamide Therapy. Arch Intern Med, 141:758–63.
Refaat MM, Katz WE, 2011, Neoplastic Pericardial Effusion. Clin Cardiol, 34:593–8.
Shields TW, 2009, General Thoracic Surgery (7th edn.). Philadelphia: Lippincott Williams & Wilkins, pp.885–90.
Tsang TS, Enriquez-Sarano M, Freeman WK, et al., 2002, Consecutive 1127 Therapeutic Echocardiographically guided Pericardiocenteses: Clinical Profile, Practice Patterns, and Outcomes Spanning 21 Years. Mayo Clin Proc, 77:429–36.
Burazor I, Imazio M, 2013, Malignant Pericardial Effusion. Cardiology, 124:224–32.
Petrofsky M, 2014, Management of Malignant Pericardial Effusion. J Adv Pract Oncol, 5:281–9.
Jama GM, 2014, Palliative Treatment for Symptomatic Malignant Pericardial Effusion. Interact Cardiovasc Thorac Surg, 19:1019–26.
Karnofsky D, Burchenal J, 1949, The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod C (ed.) Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, pp.191–205.
Oken MM, Creech RH, Tormey DC, et al., 1982, Toxicity and Response Criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 5:649–55.
Campbell PT, 1992, Subxiphoid Pericardiotomy in the Diagnosis and Management of Large Pericardial Effusions Associated with Malignancy. Chest, 101:938–43.
Hankins JR, Saterfield JR, 1980, Pericardial Window for Malignant Pericardial Effusion. Ann Thorac Surg, 30:465–71.
Sugimoto JT, Little AG, Ferguson MK, et al., 1990, Pericardial Window: Mechanisms of Efficacy. Ann Thorac Surg, 50:442–5.
Celik S, Lestuzzi C, Cervesato E, et al., 2014, Systemic Chemotherapy in Combination with Pericardial Window Has Better Outcomes in Malignant Pericardial Effusions. J Thorac Cardiovasc Surg, 148:2288–93.
Patel N, Rafique AM, Eshaghian S, et al., Retrospective Comparison of Outcomes, Diagnostic Value, and Complications of Percutaneous Prolonged Drainage Versus Surgical Pericardiotomy of Pericardial Effusion Associated with Malignancy. Am J Cardiol, 112:1235–9.
Girardi LN, Ginsberg RJ, Burt ME, 1997, Pericardiocentesis and Intrapericardial Sclerosis: Effective Therapy for Malignant Pericardial Effusions. Ann Thorac Surg, 64:1422–8.
Wilkes JD, Fidias P, Vaickus L, et al., 1995, Malignancy-Related Pericardial Effusion. 127 Cases from the Roswell Park Cancer Institute. Cancer, 76:1377–87.
Maisch B, Ristic AD, Pankuweit S, et al., 2002, Neoplastic Pericardial Effusion. Efficacy and Safety of Intrapericardial Treatment with Cisplatin. Eur Heart J, 23:1625–31.
Dequanter D, Lothaire P, Berghmans T, et al., 2008, Severe Pericardial Effusion in Patients with Concurrent Malignancy: A Retrospective Analysis of Prognostic Factors Influencing Survival. Ann Surg Oncol, 15:3268–71.
Lestuzzi C, 2010, Neoplastic Pericardial Disease: Old and Current Strategies for Diagnosis and Management. World J Cardiol, 2:270–9.
Apodaca-Cruz A, Villarreal-Garza C, Torres-Ávila B, et al., 2011, Effectiveness and Prognosis of Initial Pericardiocentesis in the Primary Management of Malignant Pericardial Effusion. Interact Cardiovasc Thorac Surg, 11:154–61.
Gillen J, Lau C, 2013, Permanent Indwelling Catheters in the Management of Pleural Effusions. Thoracic Surg Clin, 23:63–71.
Ahmad MM, 2011, The Pericardical Window: Is a Video Assisted Thoracoscopy Approach Better than Surgical Approach? Interact Cardiovasc Thorac Surg, 12:175–8.